查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1771616

美国冷冻消融探针市场规模、份额、应用趋势分析、最终用途、细分市场预测，2025-2033

U.S. Cryoablation Probes Market Size, Share & Trends Analysis By Application (Cardiac Arrhythmias, Oncology, Dermatology), By End Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers (ASCs)), And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

美国冷冻消融探针市场摘要

美国冷冻消融探针市场规模预计在 2024 年为 5,171 万美元，预计到 2033 年将达到 1.3316 亿美元，2025 年至 2033 年的复合年增长率为 11.16%。由于几个关键因素，包括需要微创治疗的心血管和肿瘤疾病的盛行率不断上升，该市场正在经历显着增长。

心血管疾病、肺癌、摄护腺癌、肝癌和肾癌等以心房颤动等心律不整为中心的慢性疾病的发生率日益上升，推动了对冷冻消融等微创治疗方案的需求。例如，根据美国心臟协会的数据，目前约有500万美国患有心房颤动（AFib），这是最常见的心律不整类型，但预计到2030年，这一数字将增至1,200万以上。

此外，根据2025年2月发表的一篇研究论文和美国心臟协会的报告，2022年，美国成年人高血压盛行率最高的州是密西西比州，为40.2%，最低的是科罗拉多，为24.6%。高血压盛行率呈现随年龄增加而上升趋势，20至44岁族群的盛行率达28.5%，45至64岁族群的盛行率达58.6%，65岁以上族群的盛行率达76.5%。因此，高血压盛行率的上升进一步推动了市场的成长。

此外，癌症盛行率的上升也有望在预测期内刺激需求。例如，根据美国癌症协会 (美国 Cancer Society) 的报告，预计到 2025 年，美国女性将新增约 316,950 例侵袭性乳癌病例，男性将新增约 2,800 例侵袭性乳癌病例。此外，预计女性将新增 59,080 例乳管原位癌 (DCIS)。预计约有 42,680 例乳癌相关死亡病例，其中女性 42,170 例，男性 510 例。

医疗技术的进步带来了更精准、更有效的冷冻消融设备，这些设备正被医疗保健专业人员广泛采用。老年人口的成长和对标靶肿瘤治疗的偏好进一步推动了市场需求。此外，监管机构的核准以及主要企业之间的策略联盟也促进了市场扩张。心臟病学、皮肤病学和疼痛管理领域应用的不断增长，也促进了市场的成长。此外，人们对微创手术的认识和接受度不断提高，加上其恢復时间更快、併发症更少等优势，也刺激了市场扩张。老年人口的成长，使他们更容易罹患癌症和其他可透过冷冻消融治疗的疾病，这进一步推动了市场需求。此外，医疗基础设施投资的活性化以及旨在改善冷冻消融技术的研究活动也促进了市场的上升趋势。总体而言，这些因素共同推动了冷冻消融探针的普及，为未来几年市场持续成长奠定了基础。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国冷冻消融探针市场变数、趋势与范围

  • 市场展望
    • 母市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 美国冷冻消融探针市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国冷冻消融探针市场：应用评估与趋势分析

  • 细分仪表板
  • 美国冷冻消融探针市场波动分析
  • 美国冷冻消融探针市场规模及应用趋势分析（2021-2033）
  • 心律不整
  • 肿瘤学
  • 皮肤科
  • 其他的

5. 冷冻消融探针设备－最终用途估计与趋势分析

  • 细分仪表板
  • 美国冷冻消融探针市场波动分析
  • 美国冷冻消融探针市场规模及趋势分析（依最终用途）（2021-2033）
  • 医院
    • 2021-2033年医院市场估计与预测
  • 专科诊所
    • 专科诊所市场估计与预测 2021-2033
  • 门诊手术中心（ASC）
    • 门诊手术中心（ASC）市场估计与预测（2021-2033）
  • 其他的
    • 2021-2033年其他市场估计与预测

第六章 竞争态势

  • 市场参与企业分类
  • 主要企业简介
    • Atricure, Inc.
    • Varian, A Siemens Healthineers Company
    • IceCure Medical
    • Medtronic
    • Bruker
    • Erbe USA, Incorporated
    • Keeler
    • HealthTronics, Inc.
  • 2024年公司市场占有率分析
  • 其他主要市场公司名单
Product Code: GVR-4-68040-623-7

U.S. Cryoablation Probes Market Summary

The U.S. cryoablation probes market size was estimated at USD 51.71 million in 2024 and is projected to reach USD 133.16 million by 2033, growing at a CAGR of 11.16% from 2025 to 2033. The market is witnessing significant growth driven by several key factors. These include the increasing prevalence of cardiovascular and oncological diseases, which necessitate minimally invasive treatment options.

Increasing prevalence of chronic diseases, such as cardiovascular diseases, mainly cardiac arrhythmia, such as atrial fibrillation, cancer, particularly lung, prostate, liver, and kidney cancers, among others, has heightened demand for minimally invasive treatment options like cryoablation. For instance, according to the American Heart Association, Inc., currently, an estimated five million Americans are living with atrial fibrillation (AFib), which is the most common type of cardiac arrhythmia, and this number is expected to increase to over 12 million by 2030.

Furthermore, according to a research article published in February 2025 and an American Heart Association report, in 2022, the highest rate of high blood pressure among U.S. adults was observed in Mississippi at 40.2%, while Colorado had the lowest at 24.6%. Hypertension prevalence tends to rise with age, reaching 28.5% among individuals aged 20 to 44, 58.6% among those aged 45 to 64, and 76.5% in adults aged 65 and older. As a result, the growing prevalence of hypertension is further driving the market growth.

In addition, the growing prevalence of cancer is also expected to boost demand during the forecast period. For instance, according to the American Cancer Society report, in the U.S. in 2025, approximately 316,950 new cases of invasive breast cancer are expected to be diagnosed in women, along with approximately 2,800 cases in men. In addition, an estimated 59,080 cases of ductal carcinoma in situ (DCIS) will be diagnosed in women. The year is projected to see around 42,680 breast cancer-related deaths, with 42,170 occurring in women and 510 in men.

Advances in medical technology have led to the development of more precise and effective cryoablation devices, enhancing their adoption among healthcare providers. The expanding geriatric population and growing preference for targeted tumor therapies further boost demand. In addition, regulatory approvals and strategic collaborations among key players enhance market expansion. Increasing applications in cardiology, dermatology, and pain management contribute to market growth. In addition, growing awareness and acceptance of minimally invasive procedures, coupled with benefits such as reduced recovery time and fewer complications, are fueling market expansion. The rising geriatric population, who are more susceptible to cancer and other conditions treatable with cryoablation, further propels demand. Moreover, the increasing investment in healthcare infrastructure and research activities aimed at improving cryoablation techniques contributes to the market's upward trajectory. Overall, these factors collectively drive the adoption of cryoablation probes, positioning the market for continued growth in the coming years.

U.S. Cryoablation Probes Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. cryoablation probes market report based on application and end use:

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Cardiac Arrhythmias
  • Oncology
    • Lung cancer
    • Prostate cancer
    • Breast cancer
    • Kidney cancer
    • Liver cancer
    • Others
  • Dermatology
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Cryoablation Probes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenge analysis
  • 3.3. U.S. Cryoablation Probes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Cryoablation Probes Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Cryoablation Probes Market Movement Analysis
  • 4.3. U.S. Cryoablation Probes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.4. Cardiac Arrhythmias
    • 4.4.1. Cardiac arrhythmias market estimates and forecast 2021 to 2033 (USD Million)
  • 4.5. Oncology
    • 4.5.1. Oncology market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.1.1. Lung Cancer
        • 4.5.1.1.1. Lung cancer market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.1.2. Prostate Cancer
        • 4.5.1.2.1. Prostate cancer market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.1.3. Breast Cancer
        • 4.5.1.3.1. Breast cancer market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.1.4. Kidney Cancer
        • 4.5.1.4.1. Kidney cancer market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.1.5. Liver Cancer
        • 4.5.1.5.1. Liver cancer market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.1.6. Others
        • 4.5.1.6.1. Lung cancer market estimates and forecast 2021 to 2033 (USD Million)
  • 4.6. Dermatology
    • 4.6.1. Dermatology market estimates and forecast 2021 to 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Cryoablation Probes Devices: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Cryoablation Probes Market Movement Analysis
  • 5.3. U.S. Cryoablation Probes Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5. Specialty Clinics
    • 5.5.1. Specialty Clinics market estimates and forecast 2021 to 2033 (USD Million)
  • 5.6. Ambulatory Surgery Centers (ASCs)
    • 5.6.1. Ambulatory Surgery Centers (ASCs) market estimates and forecast 2021 to 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
  • 6.2. Key Company Profiles
    • 6.2.1. Atricure, Inc.
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Varian, A Siemens Healthineers Company
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. IceCure Medical
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Medtronic
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Bruker
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Erbe USA, Incorporated
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Keeler
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. HealthTronics, Inc.
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
  • 6.3. Company Market Share Analysis, 2024
  • 6.4. List of Other Key Market Players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. cryoablation probes market, by application, 2021 - 2033 USD Million
  • Table 4 U.S. cryoablation probes market, by end use, 2021 - 2033 USD Million

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Cryoablation Probes Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 U.S. Cryoablation Probes Market, for Application, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. Cryoablation Probes Market, for Cardiac Arrhythmias, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. Cryoablation Probes Market, for Oncology, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. Cryoablation Probes Market, for Dermatology, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. Cryoablation Probes Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. Cryoablation Probes Market, for End Use, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. Cryoablation Probes Market, for Hospitals, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. Cryoablation Probes Market, for Specialty Clinics, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Cryoablation Probes Market, for Ambulatory Surgery Centers (ASCs), 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Cryoablation Probes Market, for Others, 2021 - 2033 (USD Million)